Clinical trial
Use of Bromodeoxyuridine to Study White Blood Cell Replication and Survival in…
NCT00001650 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00001650 |
|---|---|
| Title | Use of Bromodeoxyuridine to Study White Blood Cell Replication and Survival in HIV-Infected Patients |
| Official title | Studies of Lymphocyte Kinetics Using Bromodeoxyuridine |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | HIV Infection, Acquired Immunodeficiency Syndrome |
| Enrollment | 56 |
| Start date | Sep 19, 1997 |
| Completion | May 13, 2011 |
| First posted | Nov 4, 1999 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: